CH207498A - Process for the preparation of a derivative of the 3-keto-cyclopentanopolyhydrophenanthrene series. - Google Patents

Process for the preparation of a derivative of the 3-keto-cyclopentanopolyhydrophenanthrene series.

Info

Publication number
CH207498A
CH207498A CH207498DA CH207498A CH 207498 A CH207498 A CH 207498A CH 207498D A CH207498D A CH 207498DA CH 207498 A CH207498 A CH 207498A
Authority
CH
Switzerland
Prior art keywords
keto
derivative
preparation
intermediate product
series
Prior art date
Application number
Other languages
German (de)
Inventor
Gesellschaft Fuer Chemis Basel
Original Assignee
Chem Ind Basel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chem Ind Basel filed Critical Chem Ind Basel
Publication of CH207498A publication Critical patent/CH207498A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)

Description

  

  Verfahren zur Darstellung eines Derivates der     3-Keto-Cyclopentanopolyhydro-          phonanthren-]Reihe.       Es wurde gefunden,     dass    man zu einem  Derivat der     3-Keto-Cyclopentanopolyhydro-          phenanthren-Reihe    gelangen kann, wenn man  Testosteron mit einem     Oxalsäureester    um  setzt, und hierauf auf das so erhaltene Zwi  schenprodukt     hydrolysierende    Mittel einwir  ken     lässt.     



  Man erhält auf diese Weise den     Testo-          steroii-2-aldehyd    der folgenden Formel:  
EMI0001.0011     
    in Form farbloser Kristalle.  



  Die Umsetzung des Testosterons mit dem       Oxalsäureester    wird zweckmässig in Gegen  wart geeigneter Kondensationsmittel ausge  führt. Beispielsweise seien genannt:     Alkali-          metalle,    wie Natrium, Kalium,     Lithium,    ins-    besondere in Form ihrer     Alkoholate,        Amide     und dergleichen. Zweckmässig arbeitet man       hiebei    auch in Gegenwart eines Lösungs  mittels. Als solche kommen in Betracht zum  Beispiel Benzol,     Toluol,        Hexan,    Äther,     Petrol-          äther    und dergleichen.

   Oft ist es günstig  die Umsetzung bei erhöhter Temperatur, ge  gebenenfalls unter Druck auszuführen. Das  so entstandene Zwischenprodukt ist ein     2-          Ketocarbonsäureester,    das' durch Behandeln  mit     hydrolysierenden    Mitteln, zum Beispiel  mit verdünnter Schwefelsäure bei erhöhter  Temperatur, in den entsprechenden Aldehyd  übergeführt wird.  



  Der     Endstoff    kann jeweils mittels physi  kalischer Methoden, wie Umkristallisation,  Destillation, Sublimation,     Adsorption    oder,  unter Benützung seiner spezifischen     reaktion-          fähigen    Gruppen, zum Beispiel über seine  Kondensationsprodukte mit     Carbonylreagen-          tien    gereinigt werden.  



  Die neue Verbindung soll therapeutische      Verwendung finden oder als Zwischenprodukt  zur Herstellung therapeutisch verwendbarer  Stoffe dienen.  



  <I>Beispiel:</I>  Zu einer Suspension von<B>0,7</B> Teilen  trockenem     Natriumäthylat    in<B>50</B> Teilen ab  solutem Benzol werden zuerst<B>1,5</B> Teile     Oxal-          säurediäthylester        hinzgefügt,    wobei das       Äthylat    in Lösung geht und hierauf<B>2,9</B> Teile  Testosteron. Man erwärmt eine Stunde auf  dem Wasserbade und     lässt    dann 2 Tage bei  Zimmertemperatur stehen. Das Reaktionsge  misch wird nunmehr mit Äther verdünnt und  mit eiskaltem Wasser     ausgesehüttelt.    Die  wässerige Lösung wird sofort unter Kühlung  mit Essigsäure angesäuert und mehrmals mit  Äther extrahiert.

   Die vereinigten Ätheraus  züge werden mit Wasser gewaschen, über  wasserfreiem Natriumsulfat getrocknet und       eingedarupft.    Der so erhaltene Rückstand  kann durch     Umlösen    aus Alkoholwasser,  Essigester oder     Xylol    gereinigt werden. Der       Testosteron-oxalyläthylester    wird durch Be  handeln mit verdünnter Schwefelsäure bei  erhöhter Temperatur in den entsprechenden       Testosteron-2-aldehyd    überführt.



  Process for the preparation of a derivative of the 3-keto-cyclopentanopolyhydrophonanthrene] series. It has been found that a derivative of the 3-keto-cyclopentanopolyhydrophenanthrene series can be obtained if testosterone is reacted with an oxalic acid ester and then hydrolyzing agents can act on the intermediate product thus obtained.



  Testosteroii-2-aldehyde of the following formula is obtained in this way:
EMI0001.0011
    in the form of colorless crystals.



  The reaction of testosterone with the oxalic acid ester is expediently carried out in the presence of suitable condensing agents. Examples include: alkali metals, such as sodium, potassium, lithium, especially in the form of their alcoholates, amides and the like. It is also expedient to work in the presence of a solvent. Benzene, toluene, hexane, ether, petroleum ether and the like come into consideration as such.

   It is often advantageous to carry out the reaction at elevated temperature, if necessary under pressure. The intermediate product thus formed is a 2-ketocarboxylic acid ester which is converted into the corresponding aldehyde by treatment with hydrolyzing agents, for example with dilute sulfuric acid at elevated temperature.



  The end product can be purified using physical methods such as recrystallization, distillation, sublimation, adsorption or, using its specific reactive groups, for example via its condensation products with carbonyl reagents.



  The new compound should find therapeutic use or serve as an intermediate product for the production of therapeutically useful substances.



  <I> Example: </I> To a suspension of <B> 0.7 </B> parts of dry sodium ethylate in <B> 50 </B> parts of absolute benzene, <B> 1.5 </ B > Parts of diethyl oxalate added, the ethylate going into solution and then <B> 2.9 </B> parts of testosterone. It is heated on the water bath for one hour and then left to stand for 2 days at room temperature. The reaction mixture is now diluted with ether and shaken out with ice-cold water. The aqueous solution is immediately acidified with acetic acid while cooling and extracted several times with ether.

   The combined ether extracts are washed with water, dried over anhydrous sodium sulfate and evaporated. The residue obtained in this way can be purified by dissolving it from alcohol water, ethyl acetate or xylene. The testosterone oxalylethyl ester is converted into the corresponding testosterone-2-aldehyde by loading with dilute sulfuric acid at an elevated temperature.

 

Claims (1)

PATENTANSPRUCH: Verfahren zur Darstellung eines Derivates der 3-Keto-Cyclopeiitatiopolybydropher)an- thren-Reihe, dadurch gekennzeichnet, dass man Testosteron mit einem Oxalsäureester um setzt, und hierauf auf das so erhalteneZwi- schenprodukt hydrolysierende Mittel einwirken lässt. Man erhält auf diese Weise den Testo- steroii-2-aldeliyd der Formel EMI0002.0024 in Form farbloser Kristalle. PATENT CLAIM: Process for the preparation of a derivative of the 3-keto-cyclopeiitatiopolybydropher) an- thren series, characterized in that testosterone is reacted with an oxalic acid ester, and hydrolyzing agent is then allowed to act on the intermediate product thus obtained. In this way the testosteroii-2-aldeliyd of the formula is obtained EMI0002.0024 in the form of colorless crystals. Die neue Verbindung soll therapeutische Verwendung finden oder als Zwischenprodukt zur Herstellung therapeutisch verwendbarer Stoffe dienen. The new compound should find therapeutic use or serve as an intermediate product for the production of therapeutically useful substances.
CH207498D 1937-07-26 1937-07-26 Process for the preparation of a derivative of the 3-keto-cyclopentanopolyhydrophenanthrene series. CH207498A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH207498T 1937-07-26

Publications (1)

Publication Number Publication Date
CH207498A true CH207498A (en) 1939-11-15

Family

ID=4445570

Family Applications (1)

Application Number Title Priority Date Filing Date
CH207498D CH207498A (en) 1937-07-26 1937-07-26 Process for the preparation of a derivative of the 3-keto-cyclopentanopolyhydrophenanthrene series.

Country Status (1)

Country Link
CH (1) CH207498A (en)

Similar Documents

Publication Publication Date Title
DE1793679B2 (en) S-d&#39;-R-r-X-S&#39;-Oxo-cyclopentyl) propionic acids and their allyl esters
CH207498A (en) Process for the preparation of a derivative of the 3-keto-cyclopentanopolyhydrophenanthrene series.
CH447147A (en) Process for the preparation of 5- (3-hydroxypropyl) -5H-dibenzo (a, d) cycloheptenes
AT213862B (en) Process for the preparation of new unsaturated, optionally esterified alcohols
AT227264B (en) Process for the preparation of new derivatives of hydrogenated pyridones
AT214582B (en) Process for the preparation of 3β-hydroxy- or 3β-acyloxy-6-methyl-25D-spirost-5-ene
DE739952C (en) Process for the production of ª ‡ -Piperidino-phenylessigsaeureamid
CH242289A (en) Process for the preparation of a basic ester of a 1-aryl-cycloalkyl-1-carboxylic acid.
CH268452A (en) Process for the preparation of a basic ester.
CH268450A (en) Process for the preparation of a basic ester.
CH534681A (en) 4-benzoyl-3-phenyl-4-piperidinol derivs - with hypolipaemic properties
CH249042A (en) Process for the preparation of a basic ester of a 1-aryl-cycloalkyl-1-carboxylic acid.
CH268451A (en) Process for the preparation of a basic ester.
CH262972A (en) Process for the preparation of an imidazoline.
DE1007759B (en) Process for the production of ª ‡ -Bromo-ª ‰ -methoxyisovaleric acid
CH243017A (en) Process for the preparation of a basic ester.
CH253641A (en) Process for the preparation of 3,5-dibromo-salicoylamino-antipyrine.
CH268459A (en) Process for the preparation of a basic ester.
DE1057130B (en) Process for the production of cyclooctane oxide (1, 4)
CH397648A (en) Process for the preparation of 10-hydroxydecene-2-carboxylic acid-1
DE1095274B (en) Process for the preparation of trans-cyclopropanecarboxylic acids
CH306287A (en) Process for the preparation of a piperidine derivative.
CH357395A (en) Process for the preparation of new hydrazine derivatives
CH243019A (en) Process for the preparation of a basic ester.
CH311660A (en) Process for the production of a new basic substituted fatty acid amide.